Skip to main content

Table 1 Baseline characteristics and outcome of 16 critically ill COVID-19 patients

From: What every intensivist should know about Tocilizumab

Age (years) 55.5 [47–63] (48–63)
BMI (kg/m2) 30.5 [26–33] (27–32)
Male gender 7/16 (43.8%)
Comorbidities  
Arterial hypertension 5/16 (31.3%)
CAD 1/16 (6.3%)
COPD 1/16 (6.3%)
Diabetes mellitus 4/16 (25%)
Chronic kidney disease 3/16 (18.8%)
SOFA score at ICU admission 11 [06–12] (11–12)
Invasive mechanical ventilation 13/16 (81.3%)
ICU survival 9/16 (56.3%)
Length of ICU stay (d) 26 [18–31] (19–32)
Steroids before Tocilizumab administration 13/16 (81.3%)
  1. Results provided as absolute numbers and (percentages) or as median, [interquartile range] and (95% confidence interval), as appropriate
  2. BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, SOFA score sequential organ failure assessment score, ICU; intensive care unit